CLMP, GNG12, LOX, LY6E, MYL12B, and SOX4 were reported for the first time as prognostic signature genes for PAAD, and the mechanisms of how they regulate PAAD occurrence deserve further investigation. Here, MYL12B is linked to pancreatic adenocarcinoma.